BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Prognosis
7 results:

  • 1. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis.
    Wang L; Yu S; Chan ER; Chen KY; Liu C; Che D; Awadallah A; Myers J; Askew D; Huang AY; Maillard I; Huang D; Xin W; Zhou L
    Cancer Immunol Res; 2021 Mar; 9(3):348-361. PubMed ID: 33441309
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
    Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
    Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
    Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
    Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting notch2.
    Wang L; Hu K; Chao Y; Wang X
    J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating notch2 by sponging miR-195-5p.
    Zhou S; Yu L; Xiong M; Dai G
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1822-1832. PubMed ID: 29229388
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.
    Li R; Zhang W; Cui J; Shui W; Yin L; Wang Y; Zhang H; Wang N; Wu N; Nan G; Chen X; Wen S; Deng F; Zhang H; Zhou G; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Luu HH; Haydon RC; He TC; Deng ZL
    Curr Cancer Drug Targets; 2014; 14(3):274-85. PubMed ID: 24605944
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.